Harvard Business Review

APRIL 2, 2018

health care system, ranging from expensive imaging for benign medical conditions to routine pre-operative testing before low-risk surgeries like cataract surgery. In the last half decade, however, several new HCV treatments have been developed with cure rates exceeding 90%.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

JULY 8, 2016

Entrepreneurs in Chinese industries from animated media to applied medical research said that China’s insistence on domestic standards are resulting in less-ambitious innovation and that the education system is not supporting appropriate talent development. This presents Western companies with a fresh challenge.

Business Model 8

Business Model Innovation Company Apparel 8

Harvard Business Review

OCTOBER 23, 2014

Used to its full potential, this is predictive medicine — the ability to integrate and analyze known disease characteristics with a specific patient’s history and health status, and use the resulting insights to change outcomes and inform new directions for life sciences research and development. They’re also sharing risk.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

FEBRUARY 21, 2014

A Zurich-born manager with 10 years’ experience working in Germany and Switzerland, Xavier had just landed a few days ago in Monterrey, Mexico, at a small pharmaceutical company that was recently purchased by Xavier’s company, a major European pharmaceutical firm.

Pharmaceuticals 8

Pharmaceuticals Globalization Operations Motivation 8

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

NOVEMBER 10, 2017

Spending on corporate learning, particularly leadership development, continues to increase at a staggering pace. According to one piece of research , spending on frontline leadership development alone increased by over 310% in a three-year period. Now, all functions are not created equal when it comes to power. Insight center.

Skills 8

Skills Agility Learning-by-Doing Content 8

Harvard Business Review

MARCH 11, 2013

That can be a powerful marketing technique if you have the market muscle to pull it off. At the moment Apple can get away with this behavior, because it so powerful in the niche markets in which it operates and it has a small array of products. The struggling company was forced to share details about its Blackberry 10 platform.

Supply Chain 15

Supply Chain Open-book Software Niche Marketing 15

Harvard Business Review

NOVEMBER 28, 2017

Smart businesspeople are well aware that a deceptive firm will quickly develop a bad reputation and lose repeat and future business. Doing so entails operating more efficiently or innovating to create products that consumers value more. What processes led to the development and delivery of a given product or service?

Company 8

Company Short-term Long-term Price 8

Harvard Business Review

MARCH 16, 2015

Their concerns fell into three broad categories: talent, operating in a global marketplace, and regulation and legislation. ” CEOs also worried about whether their high potential employees were being properly developed. Operating in a Global Marketplace. One area that proved especially challenging was mobility.

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

JULY 7, 2011

The problem limiting this manager's potential is often embedded in his or her power style. In my new book, Power Genes , I explore the link between a person's family history and the power style this person frequently displays on the job. Scarcity issues within the family system are at the heart of the Pleaser power style.

Rogers 14

Rogers Morale Long-term Pharmaceuticals 14

Harvard Business Review

JUNE 20, 2017

Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency. Prasad, CEO of Dr. Reddy’s, a 33-year-old global pharmaceutical company headquartered in India that produces affordable generic medication.

Company 14

Company Agility Innovation Learning-by-Doing 14

Harvard Business Review

MAY 28, 2015

Instead, according to new research from the Center for Talent Innovation (CTI), the fundamental issue is the health care industry’s failure to develop a nuanced understanding of, and commitment to, women as consumers and decision makers.

Health Care 8

Health Care Industry First-mover Advantage Market Segmentation 8

Harvard Business Review

JUNE 30, 2014

Places full of highly mobile and in-demand workers operate more democratically. Leaders don’t necessarily gain power by dint of high rank; they need to earn it every day. Without being caught doing anything so grubby as scheming or plotting, they manage relationships and power with aplomb. How do they do that?

Politics 8

Politics Pharmaceuticals Consultative Consensus 8

Harvard Business Review

JULY 20, 2017

The innovation alone is a herculean task, but imagine being that upstart pioneer trying to develop the technology, while at the same time going up against entrenched, powerful competitors with deep industry knowledge, assets, and channels who’ve been around for a hundred years or more.

Innovation 9

Innovation Productivity Products Venture Capitalist 9

Harvard Business Review

SEPTEMBER 11, 2014

For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases.

Uncertainty 19

Uncertainty Industry Bottom-up Technology 19

Harvard Business Review

FEBRUARY 17, 2011

The interesting part of this shift is that VCs are taking a more holistic or "systems" approach to investing than they typically do in developed markets. Because of three significant challenges innovators face in emerging markets: Innovation ecosystems are not well-developed. Why do VCs in emerging markets take a systems approach?

Marketing 14

Marketing Venture Capitalist Biotechnology IPO 14

Harvard Business Review

OCTOBER 26, 2017

The innovation of the Bolognese silk makers was to operate the Lucca machine with a hydraulic wheel, instead of by hand. Long before the Industrial Revolution , Bologna used this combination of hydraulic power and technology to bring silkworm farming to Europe at scale.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

OCTOBER 24, 2017

These have forced AirBnB, Tesla, and Uber to make costly concessions to their operating practices or to exit certain markets altogether. Organized demonstrations of support by stakeholder groups can send a powerful signal to policymakers. How can new firms overcome the regulations that protect incumbents? In the U.S., Consumer clubs.

Licensing 8

Licensing Proposal Retail Long-term 8

Harvard Business Review

MAY 16, 2011

But for many years it took a hands-off approach to new product development — dictating needs, but letting vendors bid for a slot on the Sun server and sink or swim after that. They tend to play vendors off against each other and shy away from partnerships that require some sharing of power.

Software 14

Software Licensing Long-term Telecommunications 14

Harvard Business Review

MARCH 27, 2018

Facebook, at that time, allowed app developers to collect this personal data. ” By that I mean companies that control a key platform which, like a coral reef, attracts to its ecosystem users, sellers, advertisers, software developers, apps, and accessory makers. But this was not the first time its policies were violated. .”

Company 8

Company Advertising Incentives Engineering 8

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. They will not, it must be noted, alter how the role of manufacturing evolves as economies develop.

Globalization 8

Globalization Supply Chain Pharmaceuticals McKinsey 8

Harvard Business Review

OCTOBER 26, 2011

Despite these gloomy headlines, three developments in the sector give us hope that the revolution in clean energy production is far from dead: 1. When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive.

Energy 10

Energy Finance IPO Biotechnology 10

Harvard Business Review

MARCH 25, 2016

Mapping out all the steps a customer takes while interacting with your company is a powerful way to improve the experience. A few years ago, I worked with a large pharmaceutical client who wanted to improve how patients with an incurable disease self-injected their drug.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Hotels Proposal 8

Harvard Business Review

OCTOBER 26, 2015

Where only the largest organizations could operate 24-hour call centers, today, even small organizations have access to companies like Global Response. Start an online store (Shopify or BigCommerce) or get your brick-and-mortar operation up and running (Square or PayPal). But it’s not necessarily a winner-takes-all scenario.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Industry Trends 8

Harvard Business Review

JUNE 3, 2016

It includes changes in how an organization interacts with its customers, citizens, or patients; in operational processes; in business models; in supply chain relationships; and in how employees use information to generate insight. If those linkages cannot be developed, then those investments should not be pursued. Insight Center.

Tools 8

Tools Supply Chain CRM Technology 8

Harvard Business Review

SEPTEMBER 26, 2011

The market favorably receives projects with long-term payoffs, particularly those in research and development. But they would have also undermined our efforts to create new drugs, which typically take 10 to 15 years to develop, hurting the company and the people who depend on us to find new therapies over the long term. I disagree.

CEO 15

CEO Short-term Long-term Restructuring 15

Harvard Business Review

JULY 6, 2017

Through coaching, she learned to project a powerful demeanor that was genuine and compelling. Because organizations are increasingly focusing on early talent development to attract and retain young talent, it’s important to understand the best way to accelerate their growth as leaders.

Execution 11

Execution 360-Degree Feedback Executive Coaching Sample 11

Harvard Business Review

MARCH 11, 2013

That can be a powerful marketing technique if you have the market muscle to pull it off. At the moment Apple can get away with this behavior, because it so powerful in the niche markets in which it operates and it has a small array of products. The struggling company was forced to share details about its Blackberry 10 platform.

Supply Chain 8

Supply Chain Open-book Software Niche Marketing 8

Harvard Business Review

MAY 5, 2016

Within weeks there was $50 billion in business deals involving foreign companies, including the Airbus agreement (worth $25 billion) to sell 118 planes, and Italy’s state rail company’s $5 billion pact to develop the local rail network. Some powerful Iranian institutions are highly suspicious of Western influence.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

MARCH 2, 2011

The days when you could make a living responding to companies' discovery of strategy, as in "Gosh, we gotta get ourselves one of those," are gone with the 1970s (or maybe the 1990s in the "developing world"). Strategy has triumphed, the installed base is huge, no self-respecting company would be without one.

Consultative 15

Consultative Strategy McKinsey Porter 15

Harvard Business Review

FEBRUARY 4, 2013

Most of us would say it's exceptionally hard, particularly when power is concentrated in a few incumbent companies with deeply rooted vested interests. But this focused power may be a benefit, not a risk. Levi Strauss, intriguingly, has used biomimetic techniques in developing new production techniques for jeans.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

JULY 30, 2015

After interviewing several ad agency executives and marketing leaders in a diverse group of businesses — pharmaceutical, high-tech, manufacturing, retail, sports, and others — I’ve found a few common themes that could help explain what is going on. Agencies are slow. ” 2. Who owns the data?

Marketing 8

Marketing Advertising Trends Brand 8

Harvard Business Review

NOVEMBER 19, 2015

In both cases participants read about a new medication that boosts immune function and reduces occurrence of the common cold, ostensibly developed by a large pharmaceutical company. We found the same to be true for chemical formulas (and other research has shown that brain scans and scientific jargon operate in a similar way).

Press Release 8

Press Release Participative Pharmaceuticals Chemicals 8

Harvard Business Review

AUGUST 5, 2013

A pharmaceuticals company we''ve been studying decided to deploy more than 20,000 iPads and other mobile devices to the global sales force to improve its engagement with doctors in emerging and developed markets. The Real Power of Enterprise Social Media Platforms. Reinventing Corporate IT An HBR Insight Center.

Organization 8

Organization CIO Compliance CRM 8

Harvard Business Review

MAY 15, 2013

Nor can we develop good approaches to analyzing, preserving and transforming cultures. If we can define what organizational culture is , it gives us a handle on how to diagnose problems and even to design and develop better cultures. a fast-moving consumer products division vs. a pharmaceuticals division of a diversified firm).

Incentives 8

Incentives Definition Pharmaceuticals System 8

Harvard Business Review

JULY 12, 2011

In exclusive business relationships, one or the other partner will typically feel constrained and seek ways out of the deal or to create additional options that give them bargaining power with their mate. Advanced practitioners of partnership strategies have developed approaches that work for them and may work for you.

Management 11

Management Airlines How To Pharmaceuticals 11

Harvard Business Review

JUNE 24, 2015

It’s not that we lack powerful ways to approach strategy; it’s that we lack a robust way to select the right ones for the right circumstances. Positional advantage is sustainable in a classical environment: the environment is predictable and develops gradually without major disruptions.

Strategy 8

Strategy Competitive Advantage Environment Execution 8